studi
materi
chapter
reader
abl
respond
follow
case
studi
femal
seen
primari
care
physician
complain
fatigu
physic
exam
reveal
pale
conjunctiva
remaind
exam
unremark
patient
admit
experienc
heavier
normal
bleed
mens
cbc
result
wbc
l
hemoglobin
gdl
mcv
fl
mchc
platelet
l
low
mcv
blood
film
review
perform
appear
immatur
granulocyt
present
eosinophil
basophil
normal
requir
perform
manual
differenti
chapter
concentr
leukocyt
disord
caus
clonal
neoplast
chang
hematopoiet
precursor
cell
caus
genet
acquir
involv
one
lineag
neutrophil
lymphocyt
monocyt
eosinophil
basophil
affect
number
circul
cell
morpholog
mani
disord
associ
signific
clinic
manifest
although
benign
natur
primari
immunodefici
disord
caus
genet
abnorm
disrupt
normal
function
innat
adapt
immun
system
cellular
function
number
cell
affect
result
clinic
manifest
often
sever
widespread
chapter
highlight
common
wellknown
diseas
signific
peripher
blood
film
abnorm
sever
combin
immun
defici
scid
group
genet
immunodefici
affect
cellular
humor
immun
almost
patient
scid
mark
decreas
circul
cell
poorli
function
b
cell
hypogammaglobulinemia
profound
clinic
manifest
left
untreat
patient
die
within
first
two
year
life
two
exampl
scid
gc
defici
adenosin
deaminas
ada
defici
gamma
chain
defici
xlink
scid
common
form
scid
caus
mutat
gene
locat
normal
code
common
g
chain
leukocyt
receptor
bind
interleukin
interleukin
normal
provid
growth
differenti
surviv
signal
b
nk
cell
signal
disrupt
becasu
alter
leukocyt
receptor
gc
defici
patient
becom
symptomat
month
age
protect
matern
immunoglobulin
deplet
present
without
tonsil
lymph
node
along
sever
lifethreaten
recur
infect
circul
natur
killer
nk
lymphocyt
nearli
absent
b
cell
adequ
number
dysfunct
children
gc
defici
fail
thrive
death
usual
occur
age
unless
treatment
hematopoiet
stem
cell
transplant
success
gene
therapi
effect
clinic
trial
howev
signific
risk
leukem
transform
autosom
recess
adenosin
deaminas
ada
defici
repres
scid
case
caus
one
mani
mutat
ada
gene
locat
chromosom
adenosin
deaminas
key
compon
metabol
breakdown
adenosin
triphosph
atp
rna
ada
defici
result
intraand
extracellular
accumul
adenosin
lymphotox
lead
profound
decreas
b
nk
cell
patient
experi
rang
recur
lifethreaten
bacteri
viral
fungal
infect
begin
earli
life
addit
skelet
abnorm
neurolog
deficit
skin
rash
xlink
scid
stem
cell
transplant
gene
therapi
experiment
use
reconstitut
fail
immun
system
wiskottaldrich
syndrom
classifi
combin
immunodefici
rare
xlink
diseas
caus
one
mutat
gene
result
decreas
level
wasp
protein
wasp
import
cytoskelet
remodel
nuclear
transcript
hematopoiet
cell
cell
decreas
b
cell
cell
nk
cell
neutrophil
monocyt
dysfunct
lead
bacteri
viral
fungal
infect
risk
bleed
due
thrombocytopenia
small
abnorm
platelet
therapi
use
eltrombopag
romiplostim
somewhat
success
increas
platelet
count
hematopoiet
stem
cell
transplant
potenti
cur
howev
transplant
patient
develop
signific
autoimmun
cytopenia
gene
therapi
success
clinic
trial
although
substanti
risk
develop
acut
leukemia
syndrom
delet
syndrom
also
classifi
combin
immunodefici
includ
digeorg
syndrom
autosom
domin
opitz
gbbb
sedlackova
syndrom
caylor
cardiofaci
syndrom
shprintzen
syndrom
conotrunc
anomali
face
syndrom
disord
within
delet
syndrom
variabl
degre
immunodefici
absenc
decreas
size
thymu
low
number
lymphocyt
underli
genet
abnorm
microdelet
chromosom
band
like
involv
occur
approxim
birth
delet
associ
broad
rang
problem
cardiac
defect
palat
abnorm
distinct
facial
featur
development
delay
psychiatr
disord
short
statur
kidney
diseas
hypocalcemia
hematolog
issu
includ
thrombocytopenia
larg
platelet
autoimmun
cytopenia
increas
risk
malign
patient
often
treat
thymic
tissu
transplant
fulli
match
peripher
blood
cell
transplant
howev
death
rate
high
mani
succumb
diseas
year
age
classifi
antibodi
defici
bruton
tyrosin
kinas
btk
defici
xlink
agammaglobulinemia
primari
immunodefici
diseas
character
reduct
serum
immunoglobulin
isotyp
profoundli
decreas
absent
b
cell
btk
defici
caus
mutat
gene
encod
bruton
tyrosin
kinas
result
decreas
product
btk
import
b
cell
develop
differenti
signal
without
btk
lymphocyt
fail
fulli
matur
lead
sever
hypogammaglobulinemia
inabl
produc
specif
antibodi
infant
btk
defici
display
symptom
month
matern
antibodi
clear
recur
lifethreaten
bacteri
infect
ensu
risk
fungal
viral
except
enteroviru
infect
low
normal
cell
function
treatment
consist
immunoglobulin
replac
therapi
syndrom
rare
autosom
recess
diseas
immun
dysregul
case
report
worldwid
syndrom
associ
mutat
lyst
gene
chromosom
encod
protein
regul
morpholog
function
lysosomerel
organel
mani
type
cell
bodi
affect
exhibit
abnorm
larg
lysosom
contain
fuse
dysfunct
granul
clinic
manifest
begin
infanc
partial
albin
sever
recurr
lifethreaten
bacteri
infect
hematolog
find
syndrom
includ
giant
lysosom
granul
granulocyt
monocyt
lymphocyt
figur
fuse
granul
result
leukocyt
dysfunct
patient
often
bleed
issu
result
abnorm
dens
granul
platelet
death
occur
age
year
granul
cytoplasm
inclus
resembl
fuse
lysosom
granul
syndrom
granul
report
patient
acut
myeloid
leukemia
chronic
myeloid
leukemia
myelodysplast
syndrom
md
congenit
neutropenia
cn
rare
group
genet
diseas
character
low
neutrophil
count
increas
risk
infect
organ
dysfunct
high
rate
leukem
transform
cn
usual
present
first
year
life
recurr
fever
caus
bacteri
fungal
infect
often
life
threaten
improv
treatment
includ
antibiot
prophylaxi
use
granulocyt
colonystimul
factor
gcsf
decreas
morbid
mortal
rate
howev
higher
dose
gcsf
associ
increas
risk
malign
transform
twentyfour
gene
identifi
caus
cn
common
better
known
cn
describ
tabl
leukocyt
leav
circul
move
site
infect
adher
endotheli
cell
tissu
matrix
roll
along
vessel
wall
selectin
adhes
molecul
express
endotheli
cell
leukocyt
mediat
process
interact
ligand
surfac
leukocyt
slow
speed
leukocyt
circul
ligand
bind
induc
highaffin
attach
integrin
endotheli
cell
receptor
leukocyt
adhes
disord
lad
rare
autosom
recess
inherit
condit
result
inabl
neutrophil
monocyt
move
circul
site
inflamm
call
extravas
consequ
disord
recurr
sever
bacteri
fungal
infect
hematopoiet
stem
cell
transplant
cur
treatment
lad
caus
mutat
gene
encod
subunit
b
integrin
result
either
decreas
truncat
form
b
integrin
necessari
adhes
endotheli
cell
recognit
bacteria
outsidein
signal
activ
compromis
individu
lad
shortli
birth
patient
suffer
recurr
infect
often
affect
skin
mucos
infect
lymphadenopathi
splenomegali
neutrophilia
common
find
clinic
sever
includ
number
infect
surviv
depend
amount
b
integrin
produc
infant
mortal
rate
high
lad
lad
ii
present
similar
manner
lad
howev
leukocyt
normal
b
integrin
molecular
defect
code
fucos
transport
move
fucos
endoplasm
reticulum
golgi
region
fucos
need
posttransl
fucosyl
glycoconjug
requir
synthesi
selectin
ligand
lad
ii
selectin
synthesi
compromis
clinic
lad
ii
patient
recur
infect
neutrophilia
growth
retard
coars
face
physic
deform
lad
ii
defect
fucos
transport
lead
inabl
produc
function
selectin
defect
leukocyt
recruit
lead
recur
infect
clinic
find
relat
defect
fucos
transport
absenc
blood
group
h
antigen
growth
retard
neurolog
defect
lad
iii
caus
mutat
protein
along
talin
requir
activ
b
integrin
leukocyt
roll
lad
iii
leukocyt
platelet
normal
express
integrin
howev
failur
respons
extern
signal
normal
result
leukocyt
activ
clinic
lad
iii
patient
experi
mild
lad
ilik
immunodefici
recurr
infect
addit
decreas
platelet
integrin
glycoprotein
iibiiia
result
bleed
similar
seen
glanzmann
thrombasthenia
like
lad
shwachmandiamond
syndrom
sd
defect
leukocyt
motil
sd
rare
autosom
recess
diseas
caus
mutat
sbd
gene
locat
affect
sbd
protein
product
import
role
ribosom
matur
cell
prolifer
bone
marrow
microenviron
patient
usual
diagnos
infanc
exocrin
pancreat
insuffici
associ
malabsorpt
malnutrit
chronic
steatorrhea
failur
thrive
bone
marrow
failur
includ
cytopenia
myelodysplasia
increas
risk
acut
leukemia
patient
also
suffer
recur
infect
skelet
abnorm
skin
dental
problem
cognit
issu
hematopoiet
stem
cell
transplant
option
patient
bone
marrow
failur
myelodysplast
syndrom
md
acut
leukemia
chronic
granulomat
diseas
cgd
rare
condit
caus
decreas
abil
neutrophil
undergo
respiratori
burst
phagocytosi
foreign
organ
approxim
case
xlink
recess
autosom
recess
xlink
recess
patient
experi
sever
diseas
cours
shorter
lifespan
autosom
recess
patient
cgd
caus
mutat
gene
respons
protein
make
reduc
form
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
normal
condit
phagocytosi
foreign
organ
lead
phosphoryl
bind
cytosol
pho
pho
primari
granul
contain
antibacteri
neutrophil
elastas
cathepsin
g
secondari
granul
contain
cytochrom
complex
phox
phox
migrat
phagolysosom
nadph
oxidas
form
pho
pho
along
phox
combin
cytochrom
complex
superoxid
gener
phagolysosom
electron
nadph
ad
oxygen
nadph
addit
regulatori
function
gener
antimicrobi
agent
case
cgd
due
mutat
gene
implic
cgd
protein
product
list
tabl
cgd
patient
experi
lifethreaten
catalaseposit
bacteri
fungal
infect
advanc
care
includ
routin
use
prophylact
antibiot
azol
antifung
improv
clinic
cours
diseas
increas
surviv
rate
cgd
diagnos
test
use
fluoresc
probe
dihydrorhodamin
measur
intracellular
product
reactiv
oxygen
speci
whim
wart
hypogammaglobulinemia
infect
myelokathexi
syndrom
classifi
defect
intrins
innat
immun
whim
result
mutat
gene
locat
normal
protein
regul
movement
white
blood
cell
bone
marrow
peripher
blood
neutrophil
accumul
bone
marrow
myelokathexi
result
low
number
circul
neutrophil
retain
neutrophil
marrow
exhibit
degen
pyknot
morpholog
chang
addit
neutropenia
lymphopenia
monocytopenia
hypogammaglobulinemia
present
result
patient
experi
recurr
bacteri
infect
highli
suscept
human
papillomaviru
hpv
infect
lead
wart
widespread
resist
treatment
treatment
consist
antibiot
prophylaxi
immunoglobulin
replac
therapi
gcsf
receptor
antagonist
target
treatment
prove
effect
increas
neutrophil
lymphocyt
count
anomali
pha
also
known
true
congenit
pha
autosom
domin
disord
character
decreas
nuclear
segment
distinct
coars
chromatin
clump
pattern
pha
potenti
affect
leukocyt
although
morpholog
chang
obviou
matur
neutrophil
preval
pha
approxim
unit
state
disord
result
mutat
lamin
breceptor
gene
lamin
b
receptor
inner
nuclear
membran
protein
combin
btype
lamin
heterochromatin
play
major
role
leukocyt
nuclear
shape
chang
occur
normal
matur
mutat
lamin
breceptor
gene
result
morpholog
chang
characterist
pha
ph
nuclei
may
appear
round
ovoid
peanut
shape
bilob
formsth
characterist
spectaclelik
pincenez
morpholog
nuclei
attach
thin
filament
also
seen
figur
report
patient
homozyg
pha
rare
virtual
identifi
case
heterozygot
greater
neutrophil
exhibit
ph
morpholog
neutrophil
pha
appear
function
normal
heterozyg
ph
individu
clinic
normal
homozyg
ph
cognit
impair
heart
defect
skelet
abnorm
may
occur
neutrophil
similar
morpholog
pha
seen
patient
md
acut
myeloid
leukemia
myeloprolif
neoplasm
acquir
pseudopha
neutrophil
also
associ
sever
bacteri
infect
hiv
tuberculosi
mycoplasma
pneumonia
drug
known
induc
pha
morpholog
includ
immunosuppress
chemotherapi
valproat
sulfisoxazol
fluconazol
ganciclovir
hematopoiet
growth
factor
ibuprofen
nuclei
pha
neutrophil
round
oval
peanut
shape
cell
may
misclassifi
myelocyt
metamyelocyt
band
neutrophil
white
blood
cell
wbc
differenti
lead
unnecessari
test
misdiagnosi
inappropri
treatment
pha
neutrophil
maintain
normal
function
presenc
associ
inflamm
infect
caus
neutrophil
left
shift
recommend
pha
neutrophil
classifi
segment
neutrophil
appropri
interpret
comment
morpholog
differ
pha
neutrophil
normal
neutrophil
aid
differenti
two
cell
size
smaller
nucleuscytoplasm
nc
ratio
pha
neutrophil
lower
chromatin
darker
coars
dens
clump
band
neutrophil
metamyelocyt
myelocyt
metamyelocyt
myelocyt
gener
show
degre
cytoplasm
basophilia
wherea
pha
neutrophil
exhibit
nearli
colorless
cytoplasm
except
impart
normal
cytoplasm
granul
pseudopha
cell
exhibit
hypogranular
md
differenti
true
pseudopha
challeng
import
consid
number
cell
exhibit
characterist
morpholog
true
pha
number
affect
cell
higher
pseudopha
vs
respect
true
pha
wbc
lineag
affect
term
nuclear
shape
chromatin
structur
pseudopha
phenomenon
restrict
neutrophil
except
md
monocyt
eosinophil
basophil
may
affect
furthermor
true
pha
suspect
care
examin
peripher
blood
film
famili
member
may
reveal
characterist
morpholog
clinic
correl
also
help
differenti
true
pseudopha
normal
neutrophil
contain
three
five
lobe
separ
filament
hyperseg
neutrophil
five
lobe
often
associ
megaloblast
anemia
hyperseg
neutrophil
usual
larger
normal
figur
hyperseg
neutrophil
also
seen
md
repres
form
dysplasia
less
often
hyperseg
neutrophil
found
hereditari
neutrophil
hypersegment
disord
individu
asymptomat
sign
megaloblast
anemia
alderreilli
anomali
ar
rare
inherit
disord
character
granulocyt
monocyt
lymphocyt
less
often
larg
darkli
stain
metachromat
cytoplasm
granul
figur
ar
anomali
initi
report
patient
gargoyl
howev
seen
otherwis
healthi
individu
characterist
granul
call
reilli
bodi
also
found
mucopolysaccharidos
mpss
cytoplasm
granul
contain
partial
digest
mucopolysaccharid
leukocyt
function
affect
ar
ar
bodi
neutrophil
may
resembl
heavi
toxic
granul
howev
reilli
bodi
also
present
monocyt
lymphocyt
wherea
toxic
granul
occur
neutrophil
also
neutrophilia
left
shift
bodi
often
accompani
toxic
granul
associ
ar
mayhegglin
anomali
rare
autosom
domin
disord
character
variabl
thrombocytopenia
giant
platelet
disord
product
myosin
heavi
chain
type
iia
affect
megakaryocyt
matur
platelet
fragment
shed
megakaryocyt
basophil
bodylik
leukocyt
inclus
mayhegglin
anomali
compos
precipit
myosin
heavi
chain
true
bodi
consist
lamellar
row
rough
endoplasm
reticulum
individu
mayhegglin
anomali
asymptomat
mild
bleed
tendenc
relat
degre
thrombocytopenia
lysosom
storag
disord
lsd
group
inherit
enzym
defici
result
mutat
gene
code
product
lysosom
enzym
result
flaw
degrad
phagocyt
materi
buildup
undigest
substrat
within
lysosom
caus
cell
dysfunct
cell
death
rang
clinic
symptom
cell
contain
lysosom
affect
lsd
classifi
accord
underdegrad
macromolecul
accumul
cell
categori
includ
sphingolipidos
oligosaccharidos
mucolipidos
mucopolysaccharidos
mp
lipoprotein
storag
disord
lysosom
transport
defect
common
lsd
present
mp
famili
inherit
disord
mucopolysaccharid
glycoaminoglycan
gag
degrad
mp
caus
defici
activ
enzym
necessari
degrad
dermatan
sulfat
heparan
sulfat
keratan
sulfat
andor
chondroitin
sulfat
partial
degrad
materi
build
lysosom
result
seriou
physic
cognit
problem
shorten
surviv
tabl
provid
genet
clinic
inform
mp
subtyp
along
defici
enzym
accumul
substrat
peripher
blood
patient
mp
may
show
metachromat
reilli
bodi
neutrophil
monocyt
lymphocyt
macrophag
bone
marrow
also
demonstr
cytoplasm
metachromat
materi
diagnosi
reli
assay
measur
specif
enzym
involv
mp
treatment
consist
enzym
replac
therapi
hematopoiet
stem
cell
transplant
hurler
patient
emerg
therapi
includ
addit
enzym
replac
therapi
improv
antiinflammatori
gene
therapi
nanoparticl
substrat
reduct
therapi
sphingolipidos
inherit
disord
lipid
catabol
defect
figur
two
disord
gaucher
neimannpick
diseas
character
macrophag
distinct
morpholog
gaucher
diseas
common
lysosom
lipid
storag
diseas
autosom
recess
disord
caus
defect
defici
catabol
enzym
bglucocerebrosidas
gene
locat
necessari
glycolipid
metabol
result
accumul
unmetabol
substrat
sphingolipid
glucocerebrosid
macrophag
throughout
bodi
includ
osteoclast
bone
microglia
brain
least
ashkenazi
jew
carrier
genet
mutat
report
although
correl
found
specif
mutat
diseas
sever
cours
case
phenotyp
predict
genotyp
three
type
gaucher
diseas
type
far
common
neurolog
symptom
key
factor
differenti
subtyp
phenotyp
quit
heterogen
patient
asymptomat
wherea
other
experi
multitud
clinic
problem
demograph
clinic
inform
associ
three
type
gaucher
diseas
provid
tabl
bone
marrow
replac
gaucher
cell
contribut
anemia
thrombocytopenia
common
find
patient
gaucher
cell
distinct
macrophag
singl
cluster
exhibit
abund
fibrillar
bluegray
cytoplasm
striat
wrinkl
appear
sometim
describ
onion
skinlik
figur
gaucher
cell
stain
posit
trichrom
aldehyd
fuchsin
period
acidschiff
pa
acid
phosphatas
commerci
avail
test
bglucosidas
glucocerebrosidas
avail
confirm
diagnosi
genet
test
sometim
use
ashkenazi
jew
screen
common
mutat
includ
three
form
gaucher
diseas
fifteenfold
increas
develop
hematolog
malign
plasma
cell
neoplasm
chronic
lymphocyt
leukemia
nonhodgkin
lymphoma
acut
leukemia
treatment
gaucher
diseas
includ
enzym
replac
therapi
recombin
glucocerebrosidas
agent
also
avail
reduc
glucocerebrosid
allogen
stem
cell
transplant
offer
potenti
cure
howev
treatmentrel
mortal
rate
high
studi
determin
safeti
efficaci
transplant
compar
standard
care
therapi
pseudogauch
cell
found
bone
marrow
patient
thalassemia
chronic
myeloid
leukemia
acut
lymphoblast
leukemia
nonhodgkin
lymphoma
plasma
cell
neoplasm
diseas
pseudogauch
cell
like
form
result
excess
cell
turnov
overwhelm
glucocerebrosidas
enzym
rather
true
decreas
enzym
electron
microscopi
show
pseudogauch
cell
contain
tubular
inclus
describ
gaucher
cell
niemannpick
diseas
np
character
accumul
fat
cellular
lysosom
vital
organ
impair
function
lead
rang
clinic
find
np
three
subtyp
type
b
caus
recess
mutat
gene
locat
within
chromosom
region
result
defici
lysosom
hydrolas
enzym
acid
sphingomyelinas
asm
subsequ
buildup
substrat
sphingomyelin
liver
spleen
lung
mutat
report
foam
cell
seablu
histiocyt
seen
bone
marrow
foam
cell
macrophag
cytoplasm
pack
lipidfil
lysosom
appear
small
vacuol
foam
stain
figur
sea
blue
histiocyt
macrophag
lipofuscin
glycophospholipid
sphingomyelin
contain
cytoplasm
granul
diamet
appear
blue
wright
stain
type
acut
neuronopath
form
np
mostli
affect
eastern
european
jew
type
present
infanc
associ
failur
thrive
lymphadenopathi
hepatosplenomegali
vision
problem
rapid
neurodegen
declin
result
death
usual
year
age
type
less
normal
sphingomyelinas
activ
type
b
nonneuronopath
form
approxim
normal
enzym
activ
type
b
np
common
individu
northern
african
descent
present
first
decad
adulthood
variabl
clinic
cours
although
neurocognit
impair
patient
experi
massiv
hepatosplenomegali
heart
diseas
pulmonari
insuffici
diagnosi
type
b
np
base
enzymat
quantit
sphingomyelinas
activ
cell
tissu
extract
genet
test
screen
three
gene
respons
case
ashkenazi
jewish
popul
one
gene
approxim
type
b
patient
north
africa
treatment
primarili
consist
enzym
replac
therapi
although
ineffect
slow
progress
neurolog
diseas
type
patient
type
c
np
autosom
recess
lipidosi
mutat
gene
case
respect
caus
impair
cellular
traffick
homeostasi
cholesterol
result
buildup
unesterifi
cholesterol
lysosom
clinic
present
type
c
np
heterogen
regard
age
onset
type
sever
neurolog
psychiatr
symptom
well
viscer
involv
earli
diagnosi
import
substrat
reduct
therapi
slow
progress
neurolog
damag
howev
heterogen
present
diagnosi
often
challeng
suspicion
index
tool
type
c
diseas
found
highli
sensit
specif
arriv
presumpt
diagnosi
confirm
obtain
genet
test
biochem
stain
cultur
fibroblast
filipin
demonstr
unesterifi
cholesterol
cellular
vesicl
therapi
focus
symptom
relief
prognosi
type
c
np
poor
patient
die
age
year
normal
rel
neutrophil
count
adult
band
plu
segment
form
approxim
normal
absolut
neutrophil
count
anc
approxim
l
patient
neutrophil
left
shift
presenc
immatur
cell
myelocyt
cell
line
clinician
prefer
includ
metamyelocyt
myelocyt
addit
band
segment
form
calcul
anc
absolut
increas
neutrophil
greater
l
adult
l
children
call
neutrophilia
neutrophilia
occur
result
catecholamineinduc
shift
neutrophil
margin
pool
cell
normal
adher
vessel
wall
circul
pool
often
neutrophilia
occur
increas
bone
marrow
product
neutrophil
seri
transfer
neutrophil
bone
marrow
storag
pool
circul
pool
neutrophilia
often
accompani
left
shift
box
list
condit
drug
associ
neutrophilia
term
leukemoid
reaction
refer
reactiv
neutrophil
leukocytosi
greater
l
shift
left
leukemoid
reaction
usual
caus
acut
chronic
infect
metabol
diseas
inflamm
occur
part
inflammatori
respons
malign
suspect
leukemoid
reaction
chronic
myelogen
myeloid
leukemia
rule
distinguish
featur
two
list
tabl
term
leukoerythroblast
reaction
refer
simultan
presenc
immatur
neutrophil
nucleat
red
blood
cell
teardrop
red
blood
cell
rbc
leukoerythroblast
reaction
sometim
accompani
neutrophilia
leukoerythroblast
reaction
suggest
either
spaceoccupi
lesion
bone
marrow
metastat
tumor
fibrosi
lymphoma
leukemia
mark
increas
one
normal
marrow
cell
eg
erythroid
hyperplasia
seen
hemolyt
anemia
primari
myelofibrosi
neutropenia
defin
decreas
anc
less
l
white
adult
l
black
adult
risk
infect
increas
anc
fall
less
l
sever
neutropenia
l
increas
risk
agranulocytosi
refer
neutrophil
count
less
l
caus
neutropenia
increas
rate
remov
destruct
peripher
blood
neutrophil
fewer
neutrophil
releas
bone
marrow
blood
decreas
product
ineffect
hematopoiesi
neutrophil
present
bone
marrow
releas
circul
defect
decreas
ratio
circul
versu
margin
pool
neutrophil
combin
acquir
form
neutropenia
includ
much
common
congenit
syndrom
box
provid
list
acquir
caus
neutropenia
medic
common
caus
acquir
neutropenia
neutropenia
associ
almost
class
drug
result
myeloid
suppress
immunolog
respons
mani
agent
use
treat
cancer
known
induc
neutropenia
includ
tradit
myelosuppress
chemotherapeut
target
therapi
immunotherapi
nonchemotherapi
druginduc
neutropenia
agranulocytosi
often
present
idiosyncrat
reaction
annual
rate
occurr
druginduc
agranulocytosi
case
per
million
unit
state
mortal
rate
immun
neutropenia
neonat
alloimmun
neutropenia
nan
matern
immunoglobulin
g
igg
cross
placenta
bind
patern
human
neutrophil
antigen
hna
found
fetal
leukocyt
antibodyco
neutrophil
remov
circul
reticuloendotheli
system
result
anc
less
l
nine
hna
locat
fcgreceptor
iiib
fcgriiib
often
implic
nan
incid
nan
well
defin
vari
live
birth
result
infect
often
life
threaten
neutropenia
resolv
within
month
clearanc
materi
igg
autoimmun
neutropenia
associ
igg
autoantibodi
one
hna
primari
usual
present
around
month
age
diseas
tend
selflimit
patient
spontan
recov
year
age
secondari
common
adult
associ
connect
tissu
disord
felti
syndrom
hematolog
neoplasm
solid
tumor
primari
immunodefici
bacteri
viral
infect
posttransplant
complic
idiosyncrat
reaction
number
medic
immunolog
mechan
involv
druginduc
neutropenia
includ
format
immun
complex
hapten
druginduc
format
neutrophil
autoantibodi
tlymphocyt
toxic
sever
factor
influenc
number
eosinophil
circul
bone
marrow
prolifer
rate
releas
bloodstream
movement
blood
extravascular
tissu
cell
surviv
destruct
eosinophil
move
tissu
eosinophilia
defin
absolut
eosinophil
count
greater
l
major
function
eosinophil
degranul
substanc
releas
damag
offend
organ
ie
parasit
target
cell
nonmalign
caus
eosinophilia
gener
result
cytokin
stimul
especi
eosinophilia
associ
parasit
infect
especi
helminth
also
associ
allerg
reaction
includ
asthma
rhiniti
urticaria
atop
dermat
scabi
infest
scarlet
fever
hiv
primari
biliari
cirrhosi
hepat
autoimmun
disord
drug
reaction
hematolog
neoplasm
eosinopenia
defin
absolut
eosinophil
count
less
l
difficult
detect
refer
interv
low
eosinopenia
often
accompani
cytopenia
condit
result
marrow
hypoplasia
specif
involv
leukocyt
eosinopenia
report
autoimmun
disord
steroid
therapi
stress
sepsi
acut
inflammatori
state
basophil
basophilia
defin
absolut
basophil
count
greater
l
associ
chronic
myeloid
leukemia
allerg
rhiniti
hypersensit
drug
food
chronic
infect
hypothyroid
chronic
inflammatori
condit
radiat
therapi
bee
sting
monocytosi
defin
absolut
monocyt
count
greater
l
adult
greater
l
neonat
monocytosi
associ
numer
condit
role
acut
chronic
inflamm
infect
immunolog
condit
hypersensit
reaction
tissu
repair
monocytosi
often
first
sign
recoveri
myelosuppress
also
seen
congenit
cyclic
neutropenia
monocytosi
occur
period
neutropenia
cycl
list
condit
associ
monocytosi
provid
box
monocytopenia
defin
absolut
monocyt
count
less
l
rare
condit
also
involv
cytopenia
lineag
aplast
anemia
chemotherapyinduc
cytopenia
monocytopenia
found
patient
receiv
steroid
therapi
hemodialysi
sepsi
viral
infect
especi
caus
epsteinbarr
viru
ebv
also
caus
monocytopenia
profound
monocytopenia
associ
hairi
cell
leukemia
identif
lymphocytosi
vari
age
individu
children
week
year
age
higher
absolut
lymphocyt
count
adult
adult
lymphocyt
repres
circul
leukocyt
lymphocytosi
children
defin
absolut
lymphocyt
count
greater
l
wherea
adult
defin
count
greater
l
newborn
lymphocyt
count
similar
adult
lymphocytosi
usual
accompani
chang
lymphocyt
morpholog
see
tabl
list
disord
associ
reactiv
lymphocytosi
lymphocytopenia
children
defin
absolut
lymphocyt
count
less
l
wherea
adult
defin
count
less
l
nonmalign
caus
lymphocytopenia
subdivid
inherit
acquir
list
tabl
physiolog
respons
infect
inflamm
stress
administr
recombin
colonystimul
factor
csf
result
neutrophilia
often
shift
left
occasion
presenc
blast
sever
infect
inflamm
dose
csf
influenc
anc
level
immatur
neutrophil
releas
circul
addit
neutrophil
may
exhibit
chang
morpholog
toxic
granul
bodi
cytoplasm
vacuol
toxic
granul
appear
dark
blueblack
granul
cytoplasm
neutrophil
usual
segment
band
form
toxic
granul
peroxidas
posit
reflect
increas
acid
mucosubst
within
primari
azurophil
granul
may
enhanc
bactericid
activ
posit
correl
level
creactiv
protein
acut
phase
protein
number
neutrophil
toxic
granul
therefor
toxic
granul
suggest
inflamm
addit
toxic
granul
seen
variou
infect
well
patient
receiv
gcsf
toxic
granul
mimic
granul
found
alderreilli
anomali
one
help
defin
characterist
toxic
granul
case
neutrophil
equal
affect
figur
tabl
highlight
reactiv
neutrophil
morpholog
chang
associ
condit
bodi
cytoplasm
inclus
consist
remnant
ribosom
ribonucl
acid
rna
arrang
parallel
row
bodi
typic
found
band
segment
neutrophil
figur
appear
togeth
toxic
granul
intracytoplasm
pale
blue
round
elong
inclus
mm
diamet
bodi
usual
locat
close
cellular
membran
delay
prepar
blood
film
collect
may
affect
bodi
appear
grey
blue
case
may
visibl
bodi
rel
nonspecif
presenc
associ
wide
rang
condit
includ
bacteri
infect
sepsi
pregnanc
bodi
similar
appear
inclus
found
mayhegglin
anomali
howev
mayhegglin
anomali
bodylik
inclus
also
seen
eosinophil
basophil
monocyt
cytoplasm
vacuol
neutrophil
encount
less
often
toxic
granul
bodi
vacuol
gener
reflect
phagocytosi
either
self
autophagocytosi
extracellular
materi
figur
autophagocyt
vacuol
tend
small
approxim
mm
distribut
throughout
cytoplasm
autophagocytosi
induc
specimen
storag
ethylen
diamintetraacet
edta
hour
autoantibodi
acut
alcohol
exposur
high
dose
radiat
phagocyt
vacuol
induc
either
bacteria
fungi
suggest
sepsi
phagocyt
vacuol
seen
care
examin
sometim
reveal
organ
within
vacuol
phagocyt
vacuol
tend
larg
mm
often
accompani
toxic
granul
case
ehrlichiosi
anaplasmosi
increas
unit
state
past
decad
ehrlichia
anaplasma
small
oblig
intracellular
bacteria
transmit
tick
human
vertebr
host
organ
grow
cluster
morula
neutrophil
anaplasma
phagocytophilum
rare
ehrlichia
ewingii
figur
monocyt
ehrlichia
chaffeensi
figur
leukopenia
thrombocytopenia
elev
liver
enzym
common
laboratori
find
anemia
occur
half
case
ofehrlichiosi
intracellular
aggreg
purpl
color
particl
morula
neutrophil
monocyt
may
occasion
detect
first
week
infect
wrightgiemsa
stain
peripher
blood
film
buffi
coat
prepar
morula
mistaken
bodi
neutrophil
polymeras
chain
reaction
test
often
requir
confirm
diagnosi
earli
detect
essenti
antibiot
treatment
doxycyclin
effect
prevent
seriou
complic
pyknot
nuclei
neutrophil
gener
indic
immin
cell
death
pyknot
nucleu
water
lost
chromatin
becom
dens
dark
howev
chromatin
filament
still
seen
nuclear
lobe
depend
whether
cell
band
segment
form
necrot
nuclei
found
dead
neutrophil
round
nuclear
fragment
filament
chromatin
pattern
figur
increas
number
pyknot
necrot
cell
suggest
extend
amount
time
elaps
blood
collect
blood
film
prepar
cytoplasm
swell
neutrophil
result
osmot
swell
cytoplasm
increas
adhes
glass
slide
stimul
neutrophil
regardless
caus
result
variat
neutrophil
size
neutrophil
anisocytosi
figur
upper
cell
neutrophil
whose
nucleu
dehydr
make
dark
dens
note
still
filament
segment
refer
pyknot
cell
cell
also
vacuol
b
neutrophil
die
note
nucleu
disintegr
numer
round
sphere
dna
filament
refer
necrot
necrobiot
cell
eosinophil
sometim
appear
hypogranular
figur
hypogranular
eosinophil
associ
acut
lymphoblast
leukemia
hypereosinophil
syndrom
vitro
disrupt
cellular
membran
may
occur
process
make
blood
film
eosinophil
fragil
promot
accuraci
recommend
fractur
eosinophil
count
eosinophil
manual
wbc
differenti
basophil
granul
water
solubl
uncommon
partial
complet
wash
away
stain
sometim
granul
remain
pinkish
ting
around
cell
seen
hamper
proper
identif
basophil
perform
manual
wbc
differenti
reactiv
chang
monocyt
uncommon
find
reactiv
monocyt
exhibit
thin
bandlik
segment
nuclei
figur
reactiv
chang
also
includ
increas
cytoplasm
volum
irregular
cytoplasm
border
chang
granul
size
color
reactiv
monocyt
associ
infect
recoveri
myelosuppress
administr
granulocytemacrophag
csf
lymphocyt
exhibit
reactiv
morpholog
classifi
use
variou
term
includ
reactiv
variant
atyp
transform
effector
plasmacytoid
turk
cell
downey
immunoblast
intern
council
standard
hematolog
icsh
recommend
use
reactiv
lymphocyt
exhibit
morpholog
consist
benign
etiolog
abnorm
lymphocyt
morpholog
suggest
malign
clonal
etiolog
reactiv
chang
lymphocyt
morpholog
occur
lymphocyt
stimul
interact
antigen
peripher
lymphoid
organ
figur
b
lymphocyt
activ
result
transform
small
rest
lymphocyt
prolifer
larger
cell
reactiv
lymphocyt
spill
peripher
circul
reactiv
lymphocyt
often
present
heterogen
popul
variou
shape
size
variat
nuclear
cytoplasm
ratio
nuclear
shape
chromatin
pattern
clump
cell
may
contain
less
condens
chromatin
nucleoli
may
visibl
increas
basophil
cytoplasm
vari
intens
within
cell
common
find
cytoplasm
may
indent
surround
rbc
howev
cell
includ
blast
may
also
show
similar
indent
plasmacytoid
lymphocyt
type
reactiv
lymphocyt
morpholog
featur
plasma
cell
figur
cell
numer
lymphoma
waldenstrom
macroglobulinemia
may
suspect
true
plasma
cell
commonli
encount
blood
film
review
human
subclin
infect
epsteinbarr
viru
ebv
associ
sever
benign
malign
diseas
proven
caus
agent
includ
infecti
mononucleosi
im
primari
infect
ebv
occur
childhood
often
goe
unnot
earli
childhood
infect
ebv
usual
identifi
symptom
gener
mild
overlap
viral
syndrom
incub
period
im
approxim
week
time
ebv
preferenti
infect
b
lymphocyt
attach
viral
envelop
glycoprotein
complement
receptor
oropharynx
epitheli
cell
also
infect
mechan
unclear
cell
express
cellular
respons
im
import
control
infect
character
prolifer
activ
nk
lymphocyt
cell
memori
cytotox
cell
ebvctl
respons
b
cell
infect
circul
reactiv
lymphocyt
repres
activ
cell
common
clinic
manifest
im
includ
sore
throat
dysphagia
fever
chill
cervic
lymphadenopathi
fatigu
headach
absolut
lymphocytosi
present
reactiv
form
complic
gener
mild
includ
hepatosplenomegali
elev
transaminas
hemolyt
anemia
moder
thrombocytopenia
rare
case
patient
develop
aplast
anemia
dissemin
intravascular
coagul
thrombot
thrombocytopen
purpura
hemolyt
urem
syndrom
syndrom
neurolog
complic
incid
clinic
appar
im
unit
state
case
per
annual
highest
frequenc
clinic
overt
im
young
adult
age
year
although
im
report
patient
month
year
age
heterophil
antibodi
stimul
ebv
crossreact
antigen
found
sheep
hors
rbc
rapid
screen
procedur
detect
heterophil
antibodi
howev
everyon
im
produc
heterophil
antibodi
especi
children
primari
immunodefici
disord
group
inherit
diseas
innat
adapt
immun
system
often
result
sever
clinic
manifest
gc
defici
adenosin
deaminas
ada
defici
exampl
sever
combin
immun
defici
scid
character
defect
cellular
humor
immun
wide
rang
sever
clinic
symptom
death
within
first
year
life
wiskottaldrich
syndrom
combin
immunodefici
diseas
numer
hematolog
clinic
find
increas
risk
leukem
transform
digeorg
syndrom
diseas
character
sever
decreas
cell
physic
abnorm
neurolog
psychiatr
issu
hematolog
manifest
bruton
tyrosin
kinas
btk
defici
xlink
agammaglobulinemia
result
profound
decreas
b
cell
hypogammaglobulinemia
sever
lifethreaten
infect
syndrom
extrem
rare
condit
affect
variou
cell
bodi
granul
fuse
within
lysosom
disrupt
normal
function
lead
wide
rang
seriou
clinic
symptom
earli
death
congenit
neutropenia
manifest
earli
life
recurr
lifethreaten
bacteri
fungal
infect
increas
risk
leukem
transform
leukocyt
adhes
disord
aris
result
impair
abil
neutrophil
monocyt
move
site
infect
clinic
find
includ
recur
sever
infect
organomegali
neurolog
defect
shwachmandiamond
syndrom
character
exocrin
pancreat
insuffici
digest
issu
infect
physic
anomali
neurolog
defect
bone
marrow
failur
increas
risk
leukemia
chronic
granulomat
diseas
result
failur
neutrophil
respiratori
burst
ingest
organ
patient
suffer
sever
recurr
infect
howev
advanc
use
antimicrobi
agent
effect
improv
clinic
condit
whim
wart
hypogammaglobulinemia
infect
myelokathexi
syndrom
disord
white
blood
cell
wbc
movement
bone
marrow
blood
result
answer
found
appendix
follow
inherit
leukocyt
disord
caus
mutat
lamin
b
receptor
anomali
b
diseas
c
alderreilli
anomali
mayhegglin
anomali
follow
inherit
leukocyt
disord
involv
mutat
nonmuscl
myosin
heavychain
iia
anomali
b
diseas
c
alderreilli
anomali
mayhegglin
anomali
leukopenia
hypogammaglobulinemia
bacteri
infect
human
papillomaviru
infect
wart
anomali
genet
disord
result
hypolobul
matur
leukocyt
cell
confus
immatur
neutrophil
acquir
form
hyposegment
call
associ
hematolog
neoplasm
disord
alderreilli
anomali
manifest
mucopolysaccharidosi
character
metachromat
granul
leukocyt
confus
toxic
granul
mayhegglin
anomali
character
thrombocytopenia
giant
platelet
bodylik
inclus
leukocyt
case
asymptomat
lysosom
storag
disord
congenit
defici
lysosom
enzym
impair
digest
macromolecul
accumul
impair
cellular
function
mucopolysaccharidos
associ
specif
defect
enzym
necessari
degrad
glycoaminoglycan
gag
partial
digest
gag
build
disrupt
cellular
function
lead
seriou
physic
neurolog
problem
gaucher
diseas
character
defici
bglucocerebrosidas
accumul
cell
sphingolipid
lead
rang
clinic
manifest
increas
risk
malign
transform
niemannpick
diseas
caus
defici
sphingomyelinas
buildup
fat
variou
organ
bodi
result
neurolog
defect
organomegali
failur
thrive
earli
death
reactiv
chang
neutrophil
includ
left
shift
bodi
toxic
granul
vacuol
reactiv
morpholog
monocyt
includ
segment
nuclei
chang
granul
color
size
irregular
cytoplasm
border
reactiv
chang
lymphocyt
includ
increas
size
increas
basophil
cytoplasm
morpholog
heterogen
